Completed
The Bioavailability of Compounded and Generic Rapamycin in Normative Aging Individuals
The Bioavailability of Compounded and Generic Rapamycin in Normative Aging Individuals: A Retrospective Study and Review With Clinical Implications
- Sponsor
- AgelessRx (Industry)
- Enrolment
- 67 enrolled
- Conditions
- Aging
- Interventions
- Rapamycin
- Ages
- adults, older adults
- Registry
- NCT06550271
From the registry
This study collected real-world evidence to better understand and define the relative bioavailability ratio between compounded rapamycin and generic rapamycin, with a specific focus on relative efficacy in increasing rapamycin levels in the blood (blood rapamycin levels).
Primary outcomes
- define the relative bioavailability ratio between compounded rapamycin and generic rapamycin